Chlorimipramine, electroconvulsive shock and combination thereof: Differential effects of chronic treatment on apomorphine-induced behaviours and on striatal and mesocortical dopamine turnover
- 1 April 1985
- journal article
- research article
- Published by Springer Nature in Naunyn-Schmiedebergs Archiv für experimentelle Pathologie und Pharmakologie
- Vol. 329 (2) , 128-134
- https://doi.org/10.1007/bf00501201
Abstract
We studied the influence of different pretreatment regimens (Chlorimipramine-Cmi, electroconvulsive shock-ECS, and Cmi+ECS all regimens being applied for either 2 or 15 days) on the open field behaviour, on the striatal and on the prefrontal dopamine-PFC DA turnover in rats injected with either apomorphine-AP 25 μg/kg (stimulating presynaptic DA receptors), AP 200 μg/kg (stimulating postsynaptic DA receptors), or vehicle (control). In the controls, AP 25 μg/kg reduced the locomotor activity and the striatal, but not the PFC DA turnover. AP 200 μg/kg increased the locomotor activity and reduced the striatal but not the PFC DA turnover. Short-term pretreatment: ECS and Cmi+ECS prevented the decrease of striatal DA turnover after AP 25 μg/kg. No other influence of any pretreatment on behaviour or DA-turnover became significant. Long-term pretreatment: Chronic Cmi: marginally increased the open field behaviour and marginally decreased the PFC DA turnover; significantly increased the effect of AP (200 μg/kg) on striatal DA turnover and the effect of AP (25 and 200 μg/kg) on PFC DA turnover. Repeated ECS: decreased locomotion and rearing and increased PFC DA turnover; increased the effect of AP (200 μg/kg) on locomotion and on striatal DA turnover; decreased the effect of AP (25 and 200 μg/kg) on PFC DA turnover. Chronic Cmi+ECS: decreased locomotion and rearing and marginally decreased PFC DA turnover; increased the effect of AP on hyperlocomotion and on striatal DA turnover. No other influence of any chronic pretreatment on behaviour or on DA turnover became significant. The data support the view that chronic AD therapies increase DAergic functions related to postsynaptic rather than to presynaptic structures. It is suggested that the different effects of chronic Cmi and repeated ECS on AP-evoked PFC DA turnover help to understand the different influences exerted by both treatments on rats' behaviour.This publication has 31 references indexed in Scilit:
- Dopamine and depression: A review of recent evidence. III. The effects of antidepressant treatmentsBrain Research Reviews, 1983
- The role of dopamine in locomotor activity and learningBrain Research Reviews, 1983
- Effects of antidepressant drugs on dopamine uptake and metabolismJournal of Pharmacy and Pharmacology, 1982
- Cortical modulation of striatal functionBrain Research, 1982
- Increased sensitivity to dopaminergic agonists after repeated electroconvulsive shock (ECS) in ratsNeuropharmacology, 1981
- Effect of 6‐Hydroxydopamine Lesions of the Medial Prefrontal Cortex on Neurotransmitter Systems in Subcortical Sites in the RatJournal of Neurochemistry, 1980
- Afferent projections to the ventral tegmental area of Tsai and interfascicular nucleus: A horseradish peroxidase study in the ratJournal of Comparative Neurology, 1979
- Chronic treatment with antidepressants prevents the inhibitory effect of small doses of apomorphine on dopamine synthesis and motor activityLife Sciences, 1979
- Repeated electroconvulsive shock increases the behavioural responses of rats to injection of both dopamine and dibutyryl cyclic amp into the nucleus accumbensNeuropharmacology, 1978
- Afferent projections to A10 dopaminergic neurones in the rat as shown by the retrograde transport of horseradisd peroxidaseNeuroscience Letters, 1978